GNA13 loss in germinal center B cells leads to impaired apoptosis and promotes lymphoma in vivo

GNA13 is the most frequently mutated gene in germinal center (GC)-derived B-cell lymphomas, including nearly a quarter of Burkitt lymphoma and GC-derived diffuse large B-cell lymphoma. These mutations occur in a pattern consistent with loss of function. We have modeled the GNA13-deficient state excl...

Full description

Saved in:
Bibliographic Details
Published in:Blood Vol. 127; no. 22; pp. 2723 - 2731
Main Authors: Healy, Jane A., Nugent, Adrienne, Rempel, Rachel E., Moffitt, Andrea B., Davis, Nicholas S., Jiang, Xiaoyu, Shingleton, Jennifer R., Zhang, Jenny, Love, Cassandra, Datta, Jyotishka, McKinney, Matthew E., Tzeng, Tiffany J., Wettschureck, Nina, Offermanns, Stefan, Walzer, Katelyn A., Chi, Jen-Tsan, Rasheed, Suhail A.K., Casey, Patrick J., Lossos, Izidore S., Dave, Sandeep S.
Format: Journal Article
Language:English
Published: United States Elsevier Inc 02-06-2016
American Society of Hematology
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:GNA13 is the most frequently mutated gene in germinal center (GC)-derived B-cell lymphomas, including nearly a quarter of Burkitt lymphoma and GC-derived diffuse large B-cell lymphoma. These mutations occur in a pattern consistent with loss of function. We have modeled the GNA13-deficient state exclusively in GC B cells by crossing the Gna13 conditional knockout mouse strain with the GC-specific AID-Cre transgenic strain. AID-Cre+ GNA13-deficient mice demonstrate disordered GC architecture and dark zone/light zone distribution in vivo, and demonstrate altered migration behavior, decreased levels of filamentous actin, and attenuated RhoA activity in vitro. We also found that GNA13-deficient mice have increased numbers of GC B cells that display impaired caspase-mediated cell death and increased frequency of somatic hypermutation in the immunoglobulin VH locus. Lastly, GNA13 deficiency, combined with conditional MYC transgene expression in mouse GC B cells, promotes lymphomagenesis. Thus, GNA13 loss is associated with GC B-cell persistence, in which impaired apoptosis and ongoing somatic hypermutation may lead to an increased risk of lymphoma development. •In mice, loss of GNA13 in GC B cells protects against cell death and may promote genetic instability via ongoing somatic hypermutation.•Gna13 loss, in combination with MYC overexpression, promotes lymphoma in mice.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
J.A.H., A.N., and R.E.R. contributed equally to this work.
ISSN:0006-4971
1528-0020
DOI:10.1182/blood-2015-07-659938